VEGFA and neoplasm: Mechanistically, it has been shown that at metastatic sites, tumor cell-derived CCL2 recruits inflammatory monocytes to metastatic sites, where they differentiate into metastasis-associated macrophages that produce vascular endothelial growth factor-A and cathepsin S, thereby promoting cancer cell extravasation (41, 42).